Related references
Note: Only part of the references are listed.Receptor-mediated tumor targeting based on peptide hormones
Gabor Mezo et al.
EXPERT OPINION ON DRUG DELIVERY (2010)
Development of an Oxime Bond Containing Daunorubicin-Gonadotropin-Releasing Hormone-III Conjugate as a Potential Anticancer Drug
Ildiko Szabo et al.
BIOCONJUGATE CHEMISTRY (2009)
Design, Synthesis, and In Vitro Activity of Novel Drug Delivery Systems Containing Tuftsin Derivatives and Methotrexate
Katalin B. Bai et al.
BIOCONJUGATE CHEMISTRY (2008)
New Derivatives of GnRH as Potential Anticancer Therapeutic Agents
Gabor Mezo et al.
CURRENT MEDICINAL CHEMISTRY (2008)
Recent trends in targeted anticancer prodrug and conjugate design
Yashveer Singh et al.
CURRENT MEDICINAL CHEMISTRY (2008)
An insight on hyaluronic acid in drug targeting and drug delivery
Awesh K. Yadav et al.
JOURNAL OF DRUG TARGETING (2008)
Synthesis, characterization, and metabolic stability of porphyrin-peptide conjugates bearing bifunctional signaling sequences
Martha Sibrian-Vazquez et al.
JOURNAL OF MEDICINAL CHEMISTRY (2008)
Synthesis and NMR spectral studies of some 2,6-diarylpiperidin-4-one O-benzyloximes
P. Parthiban et al.
SPECTROCHIMICA ACTA PART A-MOLECULAR AND BIOMOLECULAR SPECTROSCOPY (2008)
Liberation of doxorubicin from HPMA copolymer conjugate is essential for the induction of cell cycle arrest and nuclear fragmentation in ovarian carcinoma cells
A. Malugin et al.
JOURNAL OF CONTROLLED RELEASE (2007)
Structure, enzymatic stability and antitumor activity of sea lamprey GnRH-III and its dimer derivatives
Gabor Mezo et al.
PEPTIDES (2007)
Structure-activity study on the LH- and FSH-releasing and anticancer effects of gonadotropin-releasing hormone (GnRH)-III analogs
Magdolna Kovacs et al.
PEPTIDES (2007)
Different signal responses to Lamprey GnRH-III in human cancer cells
Krisztina Hereidi-Szabo et al.
INTERNATIONAL JOURNAL OF PEPTIDE RESEARCH AND THERAPEUTICS (2006)
Importance of the central region of lamprey gonadotropin-releasing hormone III in the inhibition of breast cancer cell growth
K Herédi-Szabó et al.
PEPTIDES (2005)
Recent advances in tumor-targeting anticancer drug conjugates
S Jaracz et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2005)
Chemotherapy targeted to cancers through tumoral hormone receptors
AV Schally et al.
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2004)
Design of a multivalent galactoside ligand for selective targeting of HPMA copolymer-doxorubicin conjugates to human colon cancer cells
A David et al.
EUROPEAN JOURNAL OF CANCER (2004)
New approaches to treatment of various cancers based on cytotoxic analogs of LHRH, somatostatin and bombesin
AV Schally et al.
LIFE SCIENCES (2003)
Cathepsin B-labile dipeptide linkers for lysosomal release of doxorubicin from internalizing immunoconjugates: Model studies of enzymatic drug release and antigen-specific in vitro anticancer activity
GM Dubowchik et al.
BIOCONJUGATE CHEMISTRY (2002)
Targeted delivery of doxorubicin by HPMA copolymer-hyaluronan bioconjugates
Y Luo et al.
PHARMACEUTICAL RESEARCH (2002)
New HPMA copolymers containing doxorubicin bound via pH-sensitive linkage:: synthesis and preliminary in vitro and in vivo biological properties
T Etrych et al.
JOURNAL OF CONTROLLED RELEASE (2001)
Endogenous lectins as targets for drug delivery
N Yamazaki et al.
ADVANCED DRUG DELIVERY REVIEWS (2000)
Structure elucidation and antifungal activity of an anthracycline antibiotic, daunomycin, isolated from Actinomadura roseola
BS Kim et al.
JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY (2000)
Stability of cytotoxic luteinizing hormone-releasing hormone conjugate (AN-152) containing doxorubicin 14-O-hemiglutarate in mouse and human serum in vitro:: Implications for the design of preclinical studies
A Nagy et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Share Paper
